A Chester County jury has found in favor of a young girl diagnosed with cerebral palsy and awarded her 32.8 million dollars in a recent verdict of a birth injury lawsuit. This case stemmed from a birth injury lawsuit filed on behalf of a young girl who suffered brain damage at birth. The jury award is one of the largest on record in Chester County and will help the young girl’s family pay for future medical costs. The ...
continue reading...Philadelphia Jury Awards Large Verdict in Medical Malpractice Case
Posted January 14, 2014 in Medical Malpractice | Verdicts & Settlements
A Philadelphia jury has awarded the family of a child born prematurely a $42.9 million dollar award in a recent medical malpractice case. The verdict in Harris v. Chestnut Hill Hospital was announced on December 20, 2013. This medical malpractice case stems from injuries sustained by the Plaintiff following a premature birth at 25 weeks gestation. The suit alleged that the Defendants failed at act in a timely fashion in taking steps to protect the unborn ...
continue reading...Potential Fosamax settlement announced
Posted January 8, 2014 in Product Liability | Product News and Recalls | Uncategorized | Verdicts & Settlements
Merck & Co Inc. has offered to pay $27.7 million to settle 1,140 lawsuits filed by people who alleged that the company’s bone drug, Fosamax, caused deterioration of the jaw bone. Attorneys representing the plaintiffs and counsel for Merck disclosed the proposed settlement in court on December 9, 2013. The Fosamax settlement will have to be approved by the court, and all plaintiffs must participate in the settlement.
Fosamax is used to treat or ...
continue reading...A recent jury verdict in Lehigh County, Pennsylvania has resulted in one of the biggest jury awards for a medical malpractice case in the State over the past twenty years. The jury awarded the Plaintiff $55 million dollars following a 2 week trial. The case stems from a birth injury lawsuit that was filed on behalf of a child who suffered brain damage and other injuries as a result of the alleged failure of the doctors to perform a ...
continue reading...Johnson & Johnson Guilty Plea Helps Risperdal Lawsuits
Posted November 19, 2013 in Health | Product Liability | Product News and Recalls | Verdicts & Settlements
After a ten-year long criminal investigation, Johnson & Johnson has entered a guilty plea and will pay $2.2 billion in damages. The U.S. Department of Justice charged the company with promoting the drugs Risperdal and Invega for off-label uses (uses that were not approved by the FDA). These drugs were approved solely for the treatment of schizophrenia, but Johnson & Johnson was promoting them for non-schizophrenic patients—including children, ...
continue reading...J&J to Pay Over $2.2 Billion in False Marketing Settlement
Posted November 11, 2013 in Drug and Medical Device Lawsuits | Product News and Recalls | Verdicts & Settlements
Johnson & Johnson (J&J) and its subsidiaries have agreed to pay over $2.2 billion in criminal and civil fines arising out of false marketing claims. The company allegedly promoted off-label uses for various drugs, and provided kickbacks to doctors and pharmacists for prescribing those drugs. The drugs at issue in this suit include Risperdal, Invega (forms of antipsychotic medications), and Natrecor (heart ...
